FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169362375> ?p ?o ?g. }

• W2169362375 endingPage "3" @default.
• W2169362375 startingPage "3" @default.
• W2169362375 abstract "Skeletal-muscle differentiation is required for the regeneration of myofibers after injury. The differentiation capacity of satellite cells is impaired in settings of old age, which is at least one factor in the onset of sarcopenia, the age-related loss of skeletal-muscle mass and major cause of frailty. One important cause of impaired regeneration is increased levels of transforming growth factor (TGF)-β accompanied by reduced Notch signaling. Pro-inflammatory cytokines are also upregulated in aging, which led us hypothesize that they might potentially contribute to impaired regeneration in sarcopenia. Thus, in this study, we further analyzed the muscle differentiation-inhibition pathway mediated by pro-inflammatory cytokines in human skeletal muscle cells (HuSKMCs). We studied the modulation of HuSKMC differentiation by the pro-inflammatory cytokines interleukin (IL)-1α and tumor necrosis factor (TNF)-α The grade of differentiation was determined by either imaging (fusion index) or creatine kinase (CK) activity, a marker of muscle differentiation. Secretion of TGF-β proteins during differentiation was assessed by using a TGF-β-responsive reporter-gene assay and further identified by means of pharmacological and genetic inhibitors. In addition, signaling events were monitored by western blotting and reverse transcription PCR, both in HuSKMC cultures and in samples from a rat sarcopenia study. The pro-inflammatory cytokines IL-1α and TNF-α block differentiation of human myoblasts into myotubes. This anti-differentiation effect requires activation of TGF-β-activated kinase (TAK)-1. Using pharmacological and genetic inhibitors, the TAK-1 pathway could be traced to p38 and NFκB. Surprisingly, the anti-differentiation effect of the cytokines required the transcriptional upregulation of Activin A, which in turn acted through its established signaling pathway: ActRII/ALK/SMAD. Inhibition of Activin A signaling was able to rescue human myoblasts treated with IL-1β or TNF-α, resulting in normal differentiation into myotubes. Studies in aged rats as a model of sarcopenia confirmed that this pro-inflammatory cytokine pathway identified is activated during aging. In this study, we found an unexpected connection between cytokine and Activin signaling, revealing a new mechanism by which cytokines affect skeletal muscle, and establishing the physiologic relevance of this pathway in the impaired regeneration seen in sarcopenia." @default.
• W2169362375 created "2016-06-24" @default.
• W2169362375 creator A5000374318 @default.
• W2169362375 creator A5031238323 @default.
• W2169362375 creator A5050150107 @default.
• W2169362375 creator A5054558716 @default.
• W2169362375 creator A5060222373 @default.
• W2169362375 date "2012-01-01" @default.
• W2169362375 modified "2023-10-15" @default.
• W2169362375 title "TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A" @default.
• W2169362375 cites W1530473805 @default.
• W2169362375 cites W1558226015 @default.
• W2169362375 cites W1575383081 @default.
• W2169362375 cites W1974077493 @default.
• W2169362375 cites W1985534077 @default.
• W2169362375 cites W1990054118 @default.
• W2169362375 cites W1999902156 @default.
• W2169362375 cites W2005792688 @default.
• W2169362375 cites W2009608461 @default.
• W2169362375 cites W2022487205 @default.
• W2169362375 cites W2026515823 @default.
• W2169362375 cites W2033642648 @default.
• W2169362375 cites W2039395669 @default.
• W2169362375 cites W2041217454 @default.
• W2169362375 cites W2044368898 @default.
• W2169362375 cites W2046006768 @default.
• W2169362375 cites W2055492254 @default.
• W2169362375 cites W2076277955 @default.
• W2169362375 cites W2078192607 @default.
• W2169362375 cites W2078948729 @default.
• W2169362375 cites W2079300172 @default.
• W2169362375 cites W2080935294 @default.
• W2169362375 cites W2096090498 @default.
• W2169362375 cites W2097171062 @default.
• W2169362375 cites W2102470568 @default.
• W2169362375 cites W2111728725 @default.
• W2169362375 cites W2140841858 @default.
• W2169362375 cites W2146857824 @default.
• W2169362375 cites W2148625376 @default.
• W2169362375 cites W2160199212 @default.
• W2169362375 cites W2165209275 @default.
• W2169362375 cites W2168140872 @default.
• W2169362375 doi "https://doi.org/10.1186/2044-5040-2-3" @default.
• W2169362375 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3295657" @default.
• W2169362375 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22313861" @default.
• W2169362375 hasPublicationYear "2012" @default.
• W2169362375 type Work @default.
• W2169362375 sameAs 2169362375 @default.
• W2169362375 citedByCount "89" @default.
• W2169362375 countsByYear W21693623752012 @default.
• W2169362375 countsByYear W21693623752013 @default.
• W2169362375 countsByYear W21693623752014 @default.
• W2169362375 countsByYear W21693623752015 @default.
• W2169362375 countsByYear W21693623752016 @default.
• W2169362375 countsByYear W21693623752017 @default.
• W2169362375 countsByYear W21693623752018 @default.
• W2169362375 countsByYear W21693623752019 @default.
• W2169362375 countsByYear W21693623752020 @default.
• W2169362375 countsByYear W21693623752021 @default.
• W2169362375 countsByYear W21693623752022 @default.
• W2169362375 countsByYear W21693623752023 @default.
• W2169362375 crossrefType "journal-article" @default.
• W2169362375 hasAuthorship W2169362375A5000374318 @default.
• W2169362375 hasAuthorship W2169362375A5031238323 @default.
• W2169362375 hasAuthorship W2169362375A5050150107 @default.
• W2169362375 hasAuthorship W2169362375A5054558716 @default.
• W2169362375 hasAuthorship W2169362375A5060222373 @default.
• W2169362375 hasBestOaLocation W21693623751 @default.
• W2169362375 hasConcept C104317684 @default.
• W2169362375 hasConcept C118131993 @default.
• W2169362375 hasConcept C134018914 @default.
• W2169362375 hasConcept C148738053 @default.
• W2169362375 hasConcept C164027704 @default.
• W2169362375 hasConcept C17991360 @default.
• W2169362375 hasConcept C203014093 @default.
• W2169362375 hasConcept C207200792 @default.
• W2169362375 hasConcept C2776214593 @default.
• W2169362375 hasConcept C2776914184 @default.
• W2169362375 hasConcept C2779959927 @default.
• W2169362375 hasConcept C3763915 @default.
• W2169362375 hasConcept C55493867 @default.
• W2169362375 hasConcept C62478195 @default.
• W2169362375 hasConcept C86803240 @default.
• W2169362375 hasConcept C95444343 @default.
• W2169362375 hasConceptScore W2169362375C104317684 @default.
• W2169362375 hasConceptScore W2169362375C118131993 @default.
• W2169362375 hasConceptScore W2169362375C134018914 @default.
• W2169362375 hasConceptScore W2169362375C148738053 @default.
• W2169362375 hasConceptScore W2169362375C164027704 @default.
• W2169362375 hasConceptScore W2169362375C17991360 @default.
• W2169362375 hasConceptScore W2169362375C203014093 @default.
• W2169362375 hasConceptScore W2169362375C207200792 @default.
• W2169362375 hasConceptScore W2169362375C2776214593 @default.
• W2169362375 hasConceptScore W2169362375C2776914184 @default.
• W2169362375 hasConceptScore W2169362375C2779959927 @default.
• W2169362375 hasConceptScore W2169362375C3763915 @default.
• W2169362375 hasConceptScore W2169362375C55493867 @default.
• W2169362375 hasConceptScore W2169362375C62478195 @default.

• next